NCT06282328

Brief Summary

This study aims to evaluate the prevalence of previously undiagnosed HIV infection in the hospital setting (across various medical or surgical departments) among individuals exhibiting at least one HIV indicator condition (HIV-IC) and/or engaging in risky behaviors. This is a cross-sectional, single-center study with additional procedures. Data collection will involve clinical and laboratory data from individuals with at least one HIV-IC and/or behavioral risk factor for HIV infection admitted to the San Raffaele Hospital in Milan for any reason. The overall study duration is 24 months, with recruitment lasting 20 months. Individuals will be actively recruited from various medical or surgical units of the hospital. After obtaining informed consent, clinical and laboratory information related to the study will be collected, along with specific blood samples. The presence of at least one HIV-IC will be determined using available clinical, radiological, and laboratory parameters during hospitalization. Following informed consent, hospitalized individuals will complete a paper questionnaire, aimed at identifying behavioral risk factors for HIV infection. If at least one HIV-IC or behavioral risk factor is present, the person will be eligible for inclusion in the clinical study, and a rapid capillary HIV test will be conducted bedside. In case of a positive rapid capillary HIV test result, antigen/antibody testing and Western Blot for HIV confirmation will be performed on venous blood samples on the same day.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
300

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Feb 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 14, 2024

Completed
Same day until next milestone

Study Start

First participant enrolled

February 14, 2024

Completed
14 days until next milestone

First Posted

Study publicly available on registry

February 28, 2024

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 15, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 15, 2025

Completed
6 months until next milestone

Results Posted

Study results publicly available

March 30, 2026

Completed
Last Updated

March 30, 2026

Status Verified

March 1, 2026

Enrollment Period

1.7 years

First QC Date

February 14, 2024

Results QC Date

January 9, 2026

Last Update Submit

March 9, 2026

Conditions

Keywords

HIVScreeningHIV TestingHIV ScreeningHIV Indicator ConditionsHIV IC

Outcome Measures

Primary Outcomes (1)

  • Prevalence of HIV Infection

    The primary objective of the study is to estimate the prevalence of previously unknown HIV infection (new HIV infection) in the hospital setting among individuals exhibiting at least one HIV indicator condition (HIV-IC) and/or with presence of behavioral risk factors

    Baseline

Secondary Outcomes (4)

  • Number of HIV-IC

    Baseline

  • Number of Behavioral Risk Factors

    Baseline

  • CD4+ Lymphocytes

    Baseline

  • HIV-RNA

    Baseline

Interventions

HIV testDIAGNOSTIC_TEST

Bedside rapid capillary HIV test

Eligibility Criteria

Age14 Years+
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Individuals admitted to various Units of San Raffaele Hospital (medical or surgical area).

You may qualify if:

  • Individuals admitted to various Units of IRCCS San Raffaele Hospital.
  • Individuals aged 14 years or older.
  • Individuals meeting at least one of the following criteria:
  • Presence of at least one HIV-IC.
  • Presence of at least one behavioral risk factors for HIV infection.
  • Individuals providing specific written informed consent for the study, or minors whose parents or legal guardians provide specific written informed consent for the study.

You may not qualify if:

  • Individuals not providing specific written informed consent for the study.
  • Individuals with previously known HIV infection.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

IRCCS San Raffaele Scientific Institute

Milan, 20127, Italy

Location

MeSH Terms

Conditions

Acquired Immunodeficiency SyndromeHIV Infections

Interventions

HIV Testing

Condition Hierarchy (Ancestors)

Blood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesSlow Virus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System Diseases

Intervention Hierarchy (Ancestors)

Microbiological TechniquesClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisInvestigative Techniques

Results Point of Contact

Title
Silvia Nozza
Organization
IRCCS San Raffaele Scientific Institute

Study Officials

  • Silvia Nozza, MD

    Vita-Salute San Raffaele University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Prof

Study Record Dates

First Submitted

February 14, 2024

First Posted

February 28, 2024

Study Start

February 14, 2024

Primary Completion

October 15, 2025

Study Completion

October 15, 2025

Last Updated

March 30, 2026

Results First Posted

March 30, 2026

Record last verified: 2026-03

Locations